Yd Pharmaceutical Corp.
United StatesFDA applicant, unverified
- Devices
- 3
What Yd Pharmaceutical Corp. makes
Yd Pharmaceutical Corp. manufactures urine test strips for glucose monitoring (YD STRIP GLUCOSE U19) and general protein detection (YD STRIP GP U20, YD STRIP GPH U21). These strips are designed for point-of-care diagnostic use in detecting urinary glucose and protein levels, aiding in conditions like diabetes management and kidney function assessment.
The company’s urine test strips are classified as Class II medical devices under FDA regulations and are listed via 510(k) clearance. These products are intended for use in the United States, adhering to FDA compliance requirements for diagnostic test devices.
Catalogue
Yd Strip Gph U21 Ref K834387
Regimes: 510(k) Registry: 510(k)Yd Strip Glucose U19 Ref K834385
Regimes: 510(k) Registry: 510(k)Yd Strip Gp U20 Ref K834386
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Yd Pharmaceutical Corp. have in the registry?
The registry currently lists 3 devices for Yd Pharmaceutical Corp.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Yd Pharmaceutical Corp.'s devices?
Among its 3 most recently registered devices, Yd Pharmaceutical Corp. has devices listed in FDA 510(k) (3 devices).
What risk classes do Yd Pharmaceutical Corp.'s devices fall under?
Among its 3 most recently registered devices, the classes recorded for Yd Pharmaceutical Corp.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Yd Pharmaceutical Corp. in the registry?
The most recently registered devices listed for Yd Pharmaceutical Corp. include YD STRIP GPH U21, YD STRIP GLUCOSE U19 and YD STRIP GP U20.